Zika virus is a mosquito-borne flavivirus primarily transmitted by Aedes aegypti mosquitoes (1,2). Infection with Zika virus is asymptomatic in an estimated 80% of cases (2,3), and when Zika virus does cause illness, symptoms are generally mild and self-limited. Recent evidence suggests a possible association between maternal Zika virus infection and adverse fetal outcomes, such as congenital microcephaly (4,5), as well as a possible association with Guillain-Barre syndrome. Currently, no vaccine or medication exists to prevent or treat Zika virus infection. Persons residing in or traveling to areas of active Zika virus transmission should take steps to prevent Zika virus infection through prevention of mosquito bites (http://www.cdc.gov/zika/prevention/).
CITATION STYLE
Oster, A. M., Brooks, J. T., Stryker, J. E., Kachur, R. E., Mead, P., Pesik, N. T., & Petersen, L. R. (2016). Interim Guidelines for Prevention of Sexual Transmission of Zika Virus — United States, 2016. MMWR. Morbidity and Mortality Weekly Report, 65(5), 120–121. https://doi.org/10.15585/mmwr.mm6505e1
Mendeley helps you to discover research relevant for your work.